Skip To Main Content
Ying Hang on Muck Rack

Ying Hang

As seen in: Wiley Online Library, Pakistan Journal of Medical Sciences
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ying

Contact Ying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real‐world cohort analysis

|
By Adam S. Kittai, Ying Hang, Seema A. Bhat, Abi Clark Verified
| Wiley Online Library Verified
To the Editor: Per Surveillance, Epidemiology, and End Results (SEER) data age-adjusted death rates continue to fall for patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), with an average reduction of 2.9% yearly between 2011–2020.1 This advancement is primarily driven by the development of small molecule inhibitors (SMI); specifically Bruton's Tyrosine Kinase inhibitors (BTKi's) approved for the treatment of CLL/SLL in 2014, and BCL2 inhibitors (BCL2i) approved...
Open in Who Shared Issue with article?
See all 1 licensed articles (2 Total)